Future Oncology Journal Issues Research Articles in Part 3 of December 2020 Edition
January 18, 2021
January 18, 2021
LONDON, England, Jan. 18 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in Part 3 of its December 2020 edition:
Drug Evaluation:
* Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma
Clinical Trial Protocol:
* Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of c . . .
Drug Evaluation:
* Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma
Clinical Trial Protocol:
* Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of c . . .